Which dye gives sharper brain pictures? new study compares two MRI contrast agents

NCT ID NCT06846853

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two FDA-approved contrast agents, Gadopiclenol and Gadobutrol, to see which one makes pituitary lesions clearer on MRI scans. Ten adults with known or suspected pituitary lesions will each receive both agents in random order, and neither they nor the researchers will know which is being used. The goal is to improve image quality for diagnosing pituitary conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTRAST ENHANCED IMAGES VS. NON-CONTRAST IMAGES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Connecticut Health Center

    RECRUITING

    Farmington, Connecticut, 06030, United States